Racial Differences in the Cholesterol-Lowering Effect of Statin

J Atheroscler Thromb. 2017 Jan 1;24(1):19-25. doi: 10.5551/jat.RV16004. Epub 2016 Oct 12.

Abstract

Statin treatment to reduce low-density lipoprotein cholesterol (LDL-C) is associated with the prevention of cardiovascular events in Western patients. Similar results have been reported in studies conducted in Japan. However, the dose of statins and the degree of LDL-C reduction achieved with statins are different between Asian and Western patients. In addition, there are limited data regarding racial differences in response to statins. In this review, racial differences between Asians and Westerners in response to statins are described.

Publication types

  • Review

MeSH terms

  • Anticholesteremic Agents / pharmacology*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / ethnology*
  • Cholesterol, LDL / metabolism*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Racial Groups / statistics & numerical data*

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors